Our research papers
Clarifi ASD is supported by peer reviewed research. Read our published papers below.
Our research papers
Clarifi ASD is supported by peer reviewed research. Read our published papers below.
Validation Paper
Validation Paper
Salivary miRNA
Salivary miRNA
Comparative review
Comparative review
Oral microbiome
Oral microbiome
Diurnal oscillations
Diurnal oscillations
Saliva microRNA
Saliva microRNA
Parent perspectives
Parent perspectives
Scalable biomarkers
Scalable biomarkers
Longitudinal stability
Longitudinal stability
Epigenetics – the science behind
the Clarifi ASD diagnostic tool
Clarifi ASD represents a new biological tool to aid in the diagnosis of autism, based on epigenetics and the microbiome.
Specifically, Clarifi ASD measures the activity of genes by measuring specific RNAs and microbes in the saliva to provide a probability of an autism diagnosis.
Using state of the art next-generation sequencing, researchers at SUNY Upstate Medical University, Penn State College of Medicine and Quadrant Biosciences identified 32 features that comprise the Clarifi ASD panel.
A biological discovery
in autism spectrum disorder
Why focus on non-coding RNAs?
Every gene that encodes a protein comes under the influence of non-coding RNAs, such as microRNAs. These non-coding RNA molecules direct whether a gene makes a protein, and how much of it is made.
These RNAs are involved in a wide range of biological processes in the body, making them a robust source of biomarkers for autism.
Pioneering the field of epigenetic diagnostics
We are among the pioneers of this new approach to epigenetic diagnostics. In fact, an epigenetic saliva test like Clarifi ASD has only been possible in recent years as a result of the rapidly evolving science in this area.
For example, it was only in the past 10-15 years that scientists began to understand the biological significance of microRNAs in the body. Also, the large scale data management needed to identify, categorize, and analyze microRNA and the microbiome has just recently become available. Finally, we had the good fortune of partnering with researchers on the cutting edge of this new science.
Subscribe to Clarifi ASD
Get important details in your inbox